25 results
P
non-ICU patients
I/C
acid-suppressive medications, placebos (gastric mucosa protectants), H2-receptor antagonists, proton pump inhibitors (PPIs)
O
occurrence of SU bleeding, adverse drug events (ADEs)
P
Li QL, Yao MF, Cao RY, Zhao K, Wang XD
I/C
short dental implants, splinted and nonsplinted prostheses
O
survival rates
P
fractures involving the posterior malleolus (PM) of the ankle
I/C
cannulated screws versus plate with screw fixation, no statistically significant difference in the development of postoperative ankle osteoarthritis and functional outcomes
O
no significant difference in the development of postoperative ankle osteoarthritis and functional outcomes
P
soggetti esposti professionalmente a glifosato
I/C
esposizione professionale a glifosato, soggetti non esposti a glifosato
O
rischio di linfoma non Hodgkin (NHL) e mieloma multiplo (MM)
P
older adults without cognitive impairment
I/C
anticholinergic medications, cognitive decline or dementia
O
risk of cognitive decline or dementia
P
patients with dry eye
I/C
autologous serum treatment, artificial tear drops
O
adverse effects, quality of life, severity of the pathology, pain, corneal epitheliopathy grade
P
patients with knee osteoarthritis
I/C
offloader knee braces, use of offloader knee braces vs. no use
O
physical function, pain, quality of life, adverse events
P
None
I/C
None, None
O
None
P
orthodontic pain
I/C
analgesics, placebo
O
pain intensity
P
adult myopic eyes
I/C
AI-based intraocular lens (IOL) power calculation formulas, traditional IOL formulas
O
mean absolute error (MAE), percentage of eyes with a refractive prediction error (PE) within ±0.25, ±0.50, and ±1.00 diopters (D), median absolute error (MedAE)